CYP19A1

Gene Information
 
Gene Symbol
CYP19A1
 
Aliases
ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM
 
Entrez Gene ID
 
Gene Name
Cytochrome P450 family 19 subfamily A member 1
 
Chromosomal Location
15q21.2
 
HGNC ID
 
Summary
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

SNPs

SNP Id
Upstream Sequence
SNP
Downstream Sequence Functional Significance References
rs700519 TAGAAGTTCTGATAGCAGAAAAAAGA
C/T
GCAGGATTTCCACAGAAGAGAAACT R264C 21282199
rs710059 TAGAAGTTCTGATAGCAGAAAAAAGA
C/T
GCAGGATTTCCACAGAAGAGAAACT Intron variant 21282199

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0006694 Biological process Steroid biosynthetic process TAS 2848247
GO:0006710 Biological process Androgen catabolic process IDA 26482249
GO:2000866 Biological process Positive regulation of estradiol secretion IDA 26482249
GO:0016020 Cellular component Membrane TAS 2848247
GO:0009055 Molecular function Electron transfer activity TAS 2848247
Protein Information
 
Protein Name
Aromatase, cytochrome P-450AROM, cytochrome P450 19A1, cytochrome P450, family 19, subfamily A, polypeptide 1, cytochrome P450, subfamily XIX (aromatization of androgens), estrogen synthase, estrogen synthetase, flavoprotein-linked monooxygenase, microsomal monooxygenase
 
Function
A cytochrome P450 monooxygenase that catalyzes the conversion of C19 androgens, androst-4-ene-3,17-dione (androstenedione) and testosterone to the C18 estrogens, estrone and estradiol, respectively. Catalyzes three successive oxidations of C19 androgens: two conventional oxidations at C19 yielding 19-hydroxy and 19-oxo/19-aldehyde derivatives, followed by a third oxidative aromatization step that involves C1-beta hydrogen abstraction combined with cleavage of the C10-C19 bond to yield a phenolic A ring and formic acid (PubMed:20385561). Alternatively, the third oxidative reaction yields a 19-norsteroid and formic acid. Converts dihydrotestosterone to delta1,10-dehydro 19-nordihydrotestosterone and may play a role in homeostasis of this potent androgen. Also displays 2-hydroxylase activity toward estrone. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase)
 
Refseq Proteins
 
UniProt
 
PDB
 
Pfam
Pfam Accession Pfam ID
PF00067 p450
Pathways
 
KEGG
 
Reactome
 

Steroid hormone biosynthesis
Metabolic pathways
Ovarian steroidogenesis

 

Estrogen biosynthesis
Endogenous sterols
Defective CYP19A1 causes Aromatase excess syndrome (AEXS)

Interactions
 
STRING MINT IntAct
ENSP00000290866 P12821 P12821
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Digestive System Diseases
Fatty Liver
Endocrine System Diseases
Hypopituitarism
Aromatase deficiency
Sexual Infantilism
Hypogonadism
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
 
 
variation in gene 
 
Related 
132 women with PCOS and 200 with male-factor infertility, as controls 
Potential associations of the CYP19(TTTA)7 allele with ovarian response to standard gonadotrophin stimulation and with assisted reproduction outcome were found in PCOS women, probably due to androgen/estrogen ratio alterations. 
 
 
 
 
Related 
661 individuals [364 polycystic ovary syndrome (PCOS) patients and 297 controls]  
The rs2470152 in CYP19 was not a major etiological factor for PCOS; however, the heterozygous TC genotype may inhibit aromatase activity, resulting in hyperandrogenism, particularly in PCOS patients. 
 
Androgen excess and hyperinsulinemia 
 
 
Related 
31 PCOS patients and 27 BMI-matched women with regular cycles 
CYP19 gene expression in subcutaneous fat of PCOS patient correlated positively with systolic (p = 0.006) and diastolic blood pressure (p = 0.009). Androgen excess and hyperinsulinemia may play a role in the molecular mechanisms that activate aromatase mRNA transcription in abdominal fat tissue. 
 
 
 
 
Related 
123 patients with PCOS and 113 healthy controls 
The most common allele of the tetranucleotide TTTA repeat polymorphism in the forth intron of CYP19 gene in Han Chinese women is 11R, which was different with the previous study in European Caucasians. 
 
 
SNP rs2414096 
Rotterdam criteria 
Related 
684 individuals (386 PCOS patients and 298 controls) 
SNP rs2414096 in the CYP19 gene is associated with susceptibility to PCOS 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412